PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

$367.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Academic Press Inc
24 February 2023
Medical Device Regulation provides the current FDA-CDRH thinking on the regulation of medical devices. This book offers information on how devices meet criteria for being a medical device, which agencies regulate medical devices, how policies regarding regulation affect the market, rules regarding marketing, and laws and standards that govern testing. This practical, well-structured reference tool helps medical device manufacturers both in and out of the United States with premarket application and meeting complex FDA regulatory requirements. The book delivers a comprehensive overview of the field from an author with expertise in regulatory affairs and commercialization of medical devices.

By:  
Imprint:   Academic Press Inc
Country of Publication:   United Kingdom
Dimensions:   Height: 235mm,  Width: 191mm, 
Weight:   1.400kg
ISBN:   9780323953542
ISBN 10:   0323953549
Pages:   678
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active

Elijah Wreh is an accomplished regulatory affairs leader with a proven track record of success in the medical device industry. Comprehensive experience bringing medical devices to market from viability through design, verification, and validation to global regulatory approvals. Highly proficient at streamlining procedures, implementing best practices, and pulling a talented group of professionals together into a high-performing team. He is an adjunct professor at Case Western Reserve University and the University of Akron, a part-time lecturer at Northeastern University – College of Professional Studies, and a guest lecturer at Cleveland State University. Mr. Wreh’s lecture on regulatory aspects of the medical device product commercialization lifecycle from the United States (US); international perspectives, and provisions of the US Food and Drug Administration’s (FDA’s) risk-based medical device classification scheme, such as the Premarket Notification [(510(k)], Premarket approval (PMA), and Investigational Device Exemption (IDE) submission processes. He is also an Industry Representative for the FDA Neurological Devices Advisory Committee Panel and Vice Chairman of the Board of Directors of CommStar Credit Union. He holds a Master of Arts in Christian Ministry from Liberty University, a Master of Science in Regulatory Science from the University of St. Thomas, and a Bachelor of Science in Human Biology from Minnesota State University. A certificate in Healthcare Compliance from Seton Hall Law School and a Risk Analysis certificate from Harvard T.H. Chan School of Public Health.

See Also